| 摘要 |
<p>The use of at least one isoform of sulfatide for the production of a pharmaceutical preparation for treatment of a diabetic condition is disclosed. Also a method for treatment of a diabetic condition, wherein a therapeutically effective amount of at least one isoform of sulfatide is administered to a patient, wherein said at least one isoform of sulfatide upon administration to the patient affects the sulfatide metabolism in such a way that it results in an increased amount of sulfatide. Said isoform is preferably an isoform with 8 - 24 carbon atoms in the fatty acid chain, more preferably 14 - 18 carbon atoms, and most preferably 16 carbon atoms.</p> |
